Masimo SET ® helped significantly reduce rates of severe retinopathy of prematurity (ROP) and the need for laser treatment. 1 Masimo SET ® enabled pulse oximetry screening for critical congenital ...
Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results